2394 Federal Register / Vol. 76, No. 9 / Thursday, January 13, 2011 / Notices 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Annual Submission of the Ingredients 

Added to, and the Quantity of Nicotine 

Contained in, Smokeless Tobacco 

Manufactured, Imported, or Packaged in 

the U.S. (OMB No. 0920–0338, exp. 4/ 

30/2011)—Extension—National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC), Office on Smoking 

and Health (OSH) has the primary 

responsibility for the Department of 

Health and Human Services (HHS) 

smoking and health program. HHS’s 

overall goal is to reduce death and 

disability resulting from the use of 

smokeless tobacco products and other 

forms of tobacco use through programs 

of information, education and research. 

Since 1994, as required by the 

Comprehensive Smokeless Tobacco 

Education Act of 1986 (CSTHEA, 15 

U.S.C. 4401 et seq., Pub. L. 99–252), 

CDC has collected information about the 

ingredients used in smokeless tobacco 

products and their nicotine content. 

Respondents are commercial smokeless 

tobacco product manufacturers, 

packagers, or importers (or their 

representatives), who are required by 

the CSTHEA to submit ingredient 

reports to HHS on an annual basis. 

Respondents are not required to 

submit specific forms; however, they are 

required to meet reporting guidelines 

and to submit the ingredient report by 

chemical name and Chemical Abstract 

Service (CAS) Registration Number, 

consistent with accepted reporting 

practices for other companies currently 

required to report ingredients added to 

other consumer products. Typically, 

respondents submit a summary report to 

CDC with the ingredient information for 

multiple products, or a statement that 

there are no changes to their previously 

submitted ingredient report. 

Ingredient reports for new products 

are due at the time of first importation. 

Thereafter, ingredient reports are due 

annually on March 31. Information is 

submitted to OSH by mailing a written 

report on the respondent’s letterhead, by 

CD, three-inch floppy disk, or thumb 

drive. Electronic mail submissions are 

not accepted. 

Upon receipt and verification of the 

annual ingredient and nicotine data 

reports, OSH issues a Certificate of 

Compliance to the respondent. OSH also 

uses the information to report to the 

Congress (as deemed appropriate) 

discussing the health effects of these 

ingredients. 

In this Extension request, there no 

changes to the estimated number of 

respondents, the estimated burden per 

response, or the information collection 

methods. There are no costs to 

respondents other than their time. The 

total estimated annualized burden hours 

are 18,843. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Smokeless Tobacco Manufacturers, Packagers, and Importers ................................................ 11 1 1,713 

Dated: January 6, 2011. 

Carol E. Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2011–470 Filed 1–12–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Title: Evaluation of the Head Start 

Safe Families Safe Homes Training 

Curriculum. 

OMB No.: New Collection. 

Description: The purpose of this 

collection is to examine the 

implementation of the Head Start Safe 

Families Safe Homes domestic violence 

training curriculum. The Office of Head 

Start, within the Administration for 

Children and Families (ACF) of the 

Department of Health and Human 

Services (HHS), is partnering with the 

Division of Family Violence Prevention 

of the Family and Youth Services 

Bureau of the Administration on 

Children, Youth and Families, also 

located within ACF, in an effort to 

expand the knowledge base of Head 

Start staff and build stronger 

partnerships with domestic violence 

service providers in local communities. 

Teams of trainers in each of five states 

will lead training sessions for 50 

participants. The follow-up evaluation 

will examine implementation of the 

training curriculum; changes in 

participant knowledge and changes in 

communication; collaboration; and 

service delivery related to domestic 

violence. All participants in the local 

trainings will be asked to complete 

several brief surveys, which will be 

conducted online or by phone. A 

subsample of participants will also be 

asked to complete a semi-structured 

phone interview. 

Respondents: Head Start staff. 

ANNUAL BURDEN ESTIMATES

Instrument 

Annual 

number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

hours per 

response 

Total annual 

burden hours 

Knowledge of Domestic Violence Survey ...................................................... 250 1 .25 63 

Collaboration Quality Survey ......................................................................... 250 1 .25 63 

Services & Referrals Survey ......................................................................... 250 1 .125 31 

Domestic Violence Knowledge, Attitudes, and Practices: Semi-Structured 

Interview ..................................................................................................... 20 1 .5 10 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 76, No. 9 / Thursday, January 13, 2011 / Notices 2395 

Estimated Total Annual Burden 

Hours: 167. 

In compliance with the requirements 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, ACE 

is soliciting public comment on the 

specific aspects of the information 

collection described above. Copies of 

the proposed collection of information 

can be obtained and comments may be 

forwarded by writing to the Office of 

Planning, Research and Evaluation, 

ACE, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: OPRE 

Reports Clearance Officer. E-mail 

address: 

OPREinfocollection@acf.hhs.gov. All 

requests should be identified by the title 

of the information collection. 

The Department specifically requests 

comments on (a) whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: January 6, 2011. 

Steven M. Hanmer, 

Reports Clearance Officer. 

[FR Doc. 2011–412 Filed 1–12–11; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0019] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Customer/Partner 

Service Surveys 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

voluntary customer satisfaction service 

surveys to implement Executive Order 

12862. 

DATES: Submit either electronic or 

written comments on the collection of 

information by March 14, 2011. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http:// 

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management, Food and Drug 

Administration, 1350 Piccard Dr., PI50– 

400B, Rockville, MD 20850, 301–796– 

3794, 

Jonnalynn.capezzuto@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

Agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined in 

44 U.S.C. 3502(3) and 5 CFR 1320.3(c) 

and includes Agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal Agencies 

to provide a 60-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, FDA invites 

comments on these topics: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of FDA’s functions, including whether 

the information will have practical 

utility; (2) the accuracy of FDA’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques, 

when appropriate, and other forms of 

information technology. 

Customer/Partner Service Surveys (OMB 

Control Number 0910–0360)—Extension 

Under section 903 of the Federal 

Food, Drug, and Cosmetic Act (21 U.S.C. 

393), FDA is authorized to conduct 

research and public information 

programs about regulated products and 

responsibilities of the agency. Executive 

Order 12862, entitled, ‘‘Setting Customer 

Service Standard,’’ directs Federal 

agencies that ‘‘provide significant 

services directly to the public’’ to 

‘‘survey customers to determine the kind 

and quality of services they want and 

their level of satisfaction with existing 

services.’’ FDA is seeking OMB 

clearance to conduct a series of surveys 

to implement Executive Order 12862. 

Participation in the surveys is 

voluntary. This request covers 

customer/partner service surveys of 

regulated entities, such as food 

processors; cosmetic drug, biologic and 

medical device manufacturers; 

consumers; and health professionals. 

The request also covers ‘‘partner’’ (State 

and local governments) customer 

service surveys. 

FDA will use the information from 

these surveys to identify strengths and 

weaknesses in service to customers/ 

partners and to make improvements. 

The surveys will measure timeliness, 

appropriateness and accuracy of 

information, courtesy and problem 

resolution in the context of individual 

programs. 

FDA estimates conducting 15 

customer/partner service surveys per 

year, each requiring an average of 15 

minutes for review and completion. We 

estimate respondents to these surveys to 

be between 100 and 10,000 customers. 

Some of these surveys will be repeats of 

earlier surveys for purposes of 

monitoring customer/partner service 

and developing long-term data. 

FDA estimates the burden of this 

collection of information as follows: 


srobinson on DSKHWCL6B1PROD with NOTICES